Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-04

Clinical Trial Update: Comparing NicoBloc to Nicotine Lozenges [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing NicoBloc to nicotine lozenges has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NicoBloc

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Smoking Cessation, Nicotine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-04-04